To include your compound in the COVID-19 Resource Center, submit it here.

FDA issues guidance for rare pediatric disease drug development

FDA issued draft guidance on Wednesday aimed at accelerating clinical development of treatments for pediatric rare diseases. The guidance builds

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE